Concentra Group Holdings Parent (CON) Following Kansas City Airport Expansion Has Valuation Back In Focus

Concentra Group Holdings Parent (CON) is in focus after announcing a new medical center at Kansas City Airport in Missouri, expanding access to occupational medicine for employers in a key business and transportation hub.

See our latest analysis for Concentra Group Holdings Parent.

Concentra Group Holdings Parent's recent Kansas City Airport expansion comes as the stock trades at $31.61, with a 30 day share price return of 4.74% and a strong year to date share price return of 62.85%. The 1 year total shareholder return is 62.55%, suggesting momentum has been building over recent months.

If this kind of focused healthcare growth story has your attention, it could be a good moment to see what else is moving in specialist medical services through our 40 healthcare AI stocks

Concentra Group Holdings Parent's expansion at Kansas City Airport sits alongside a powerful recent share price run, leaving an open question for investors: is this mainly about improving business fundamentals, or sentiment catching up, and how does the valuation stack up now?

Most Popular Narrative: 5.3% Undervalued

The most followed narrative on Concentra Group Holdings Parent puts fair value at $33.38 versus the last close at $31.61, framing the Kansas City Airport expansion against a modest valuation gap.

The analysts have a consensus price target of $33.38 for Concentra Group Holdings Parent based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $37.0, and the most bearish reporting a price target of just $28.0.

Read the complete narrative.

Want to see what is sitting underneath that fair value gap for Concentra Group Holdings Parent? The narrative focuses on revenue expansion, firmer margins and an earnings profile that assumes a premium P/E multiple without characterizing the company as a hyper growth story.

Result: Fair Value of $33.38 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the Concentra Group Holdings Parent story could shift if organic visit growth remains muted or if elevated leverage limits flexibility, especially as industry tech risks build.

Find out about the key risks to this Concentra Group Holdings Parent narrative.

Another View on Concentra Group Holdings Parent's Valuation

While the analyst narrative puts Concentra Group Holdings Parent modestly below fair value at $33.38, the current P/E of 23.1x tells a slightly different story. It sits just below the US Healthcare industry average of 25.9x, yet above the fair ratio estimate of 21.8x, which points to some valuation stretch.

That gap looks small in percentage terms but can matter if sentiment cools, since even a move toward the fair ratio could cap upside or amplify downside, depending on how earnings unfold. The question for investors is whether Concentra's growth and quality justify paying more than that fair ratio suggests.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Does the mix of optimism and caution around Concentra Group Holdings Parent fit with how you see the stock, or does it feel out of line with the data? If you want to move quickly and firm up your own view, take a closer look at the 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Concentra Group Holdings Parent?

Once you have formed a view on Concentra Group Holdings Parent, consider broadening your search. The next strong opportunity might be sitting in plain sight on your stock list.

• Target potential mispricings by scanning a curated set of 49 high quality undervalued stocks that combine solid fundamentals with room for sentiment to shift.
• Prioritize resilience by reviewing 79 resilient stocks with low risk scores that aim to keep drawdowns in check when markets turn choppy.
• Look for earlier-stage ideas by studying a screener containing 19 high quality undiscovered gems before they attract wider attention and reduce the potential edge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com